Treatment Survival Prognostic factors Aged Guidelines Biomarker Inflammation Microfluidics Neoplasms Classification DNA repair Dendritic cells Obesity Colorectal cancer Epidemiology Artificial intelligence Angiogenesis Mouse Ovarian cancer Radiotherapy Radiation therapy Breast cancer Cancer Migration Therapy Surgery Lymphoma Carcinoma PET Recurrence Autophagy Dosimetry Actin Diagnosis Cell migration Quality of life Mutation Immune checkpoint inhibitors Medicine PET/CT Mortality Apoptosis Oxidative stress Cervical cancer Melanoma Leukemia Liver P53 Head and neck cancer Genetics Middle Aged Ionizing radiation Humans Oncology Mitochondria Hepatocellular carcinoma Lung cancer Metabolism Cancer du sein Targeted therapy Macrophages Human Glioblastoma Adult Biomarkers NSCLC Chemotherapy Aging Deep learning Clinical trial PARIS team MRI Bladder cancer Immunotherapy Cytoskeleton Prognosis Prostate cancer Chromatin Machine learning COVID-19 Resistance Metastasis Toxicity Radiothérapie Animals Male Tumor Epigenetics Overall survival Radiomics Bevacizumab Genomics Transcription France Gene expression Homologous recombination Precision medicine Female Hypoxia Tumor microenvironment